Verily, Google’s life sciences division, is undergoing another round of layoffs as part of a strategic restructuring. CEO Stephen Gillett announced the workforce reductions in a memo, emphasizing a shift towards core priorities like precision health, data, and AI. The company is winding down its Devices program, impacting employees who contributed to medical device innovations. Verily, Google’s life sciences division, is undergoing another round of layoffs as part of a strategic restructuring. CEO Stephen Gillett announced the workforce reductions in a memo, emphasizing a shift towards core priorities like precision health, data, and AI. The company is winding down its Devices program, impacting employees who contributed to medical device innovations.
